--- title: "Weekly Recap | Accenture +0.88%, consensus target below spot" type: "News" locale: "en" url: "https://longbridge.com/en/news/304719007.md" description: "Accenture (ACN) edged up 0.88% this week to $260.50, while the S&P 500 fell 2.68%, putting the stock about 3.56 percentage points ahead of the benchmark. The weekly range was wide at 9.74%, tracing a choppy rally-and-fade pattern: Monday opened at $255.70 and pushed higher, Tuesday saw a 5.07% drop to $247.72 in intraday trading, Wednesday’s low of $246.86 marked the weekly bottom before a strong rebound to $264.27, Thursday hit a weekly high of $271." datetime: "2026-11-07T06:46:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/304719007.md) - [en](https://longbridge.com/en/news/304719007.md) - [zh-HK](https://longbridge.com/zh-HK/news/304719007.md) generator: "portal-rs" --- # Weekly Recap | Accenture +0.88%, consensus target below spot ## The Week Accenture (ACN) edged up 0.88% this week to $260.50, while the S&P 500 fell 2.68%, putting the stock about 3.56 percentage points ahead of the benchmark. The weekly range was wide at 9.74%, tracing a choppy rally-and-fade pattern: Monday opened at $255.70 and pushed higher, Tuesday saw a 5.07% drop to $247.72 in intraday trading, Wednesday’s low of $246.86 marked the weekly bottom before a strong rebound to $264.27, Thursday hit a weekly high of $271.76, and Friday settled back at $260.50. Average daily volume for the week was 6.0m shares, slightly above the 60-day median of 5.67m. ## Key Events Two storylines drove the news flow this week. The first was a controversy over AI research quality: multiple outlets reported on Wednesday that Accenture was accused of publishing a research report riddled with AI hallucinations, making it the most prominent company-specific negative item of the week. The second was the broader rotation among AI platform leaders, with Accenture featuring in investor discussions as a representative IT consulting name; the stock dropped more than 5% intraday on Tuesday, then outperformed competitors on a strong trading day Thursday. Separately, Asia Pacific co-CEO Atsushi Egawa disclosed a sale of $2.7m worth of common shares on Friday, a routine filing that was nonetheless noted by the market. No material announcements were recorded during the week. ## Analyst Ratings Among 30 institutions covering Accenture, 8 rate it buy, 2 rate it overweight, 17 rate it hold, and 3 have no opinion, with no underweight or sell ratings. The consensus rating is buy, with a consensus target price of $229.74, about 11.8% below the current price of $260.50, suggesting the target has lagged the share price move. The target range spans $163.00 to $300.00, a wide spread that highlights meaningful dispersion among analysts. Within the IT consulting industry, Accenture ranks second out of 36 comparable names. ## The Week Ahead On the macro front, US CPI and core CPI data land on Tuesday 10 November; expectations point to core CPI easing to 0.2% month-on-month and rising to 2.8% year-on-year, which could shift risk appetite for high-valuation AI platform names. For the company, Accenture’s fiscal Q1 2027 results are scheduled for 17 December before the open, with an estimated EPS of $3.94 and revenue of $19.4bn. That report will be the next checkpoint for quantifying AI-related traction and consulting demand after this week’s controversy and sector rotation. ## In Short Accenture managed a gain against a falling market this week, but the path was uneven. The AI research quality dispute and rotation sentiment took turns driving intraday moves. The analyst picture is mixed: a buy consensus sits alongside a consensus target below spot, and a high industry ranking coexists with a wide target range, suggesting disagreement has not narrowed. Valuation multiples are moderate, with a P/E of 18.57x and P/B of 4.92x. Next week’s US CPI and the December earnings report will be the key inputs for judging whether the stock can hold above the $260 level. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [ACN.US](https://longbridge.com/en/quote/ACN.US.md) ## Related News & Research - [BUZZ-Street View: Accenture’s AI act impresses, but the encore matters](https://longbridge.com/en/news/300771154.md) - [Accenture eyes sale of Chinese operations for up to $1.5bn](https://longbridge.com/en/news/302240839.md) - [AISP: $16.7M 9M revenue, record backlog and pipeline, and Praxis outcome-priced AI expansion](https://longbridge.com/en/news/304879953.md) - [NAVER D2SF-backed MOVIN Raises KRW 10 Billion Series A to Expand from Motion Capture to Motion Data Infrastructure](https://longbridge.com/en/news/304882348.md) - [Google to introduce two variants of in-house chips, Bloomberg News reports](https://longbridge.com/en/news/304854057.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**